Absolute risk prediction of second primary thyroid cancer among 5-year survivors of childhood cancer
Combined Modality Therapy
Neoplasms, Second Primary
We developed and validated three absolute risk models for second primary thyroid cancer. Model M2, with basic prior treatment information, could be useful for monitoring thyroid cancer risk in childhood cancer survivors.